The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases - EP3025719

The patent EP3025719 was granted to Miltenyi Biotec on Sep 26, 2018. The application was filed on Nov 25, 2015 under application number EP15196309A. The patent is currently recorded with a legal status of "Revoked".

EP3025719

MILTENYI BIOTEC
Application Number
EP15196309A
Filing Date
Nov 25, 2015
Status
Revoked
Sep 1, 2023
Publication Date
Sep 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEJun 26, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2711418
DESCRIPTIONUS2012309091
DESCRIPTIONWO2012012667
DESCRIPTIONWO2014059173
DESCRIPTIONWO2014127261
DESCRIPTIONWO2015017214
DESCRIPTIONWO2015090229
DESCRIPTIONWO2015142661
DESCRIPTIONWO2015150771
OPPOSITIONWO2012012667
OPPOSITIONWO2017066760
OPPOSITIONWO2017079400

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents